Global Stock Story


USD 2.67  0.08  3.09%   

Global Cord Blood is scheduled to announce its earnings tomorrow. Global Cord Earnings per Basic Share are quite stable at the moment as compared to the past year. The company's current value of Earnings per Basic Share is estimated at 5.19. Earnings per Diluted Share is expected to rise to 5.19 this year, although the value of Average Assets will most likely fall to about 7.4 B. As many millenniums are trying to avoid healthcare space, it makes sense to outline Global Cord Blood a little further and try to understand its current market patterns. We will analyze why Global Cord investors may still consider a stake in the business.
Published over a month ago
View all stories for Global Cord | View All Stories

Will Global (NYSE:CO) continue to grow in August?

The company reports 1.7 M of total liabilities.
The company retains a Market Volatility (i.e., Beta) of 0.5755, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Global's beta means in this case. As returns on the market increase, Global Cord returns are expected to increase less than the market. However, during the bear market, the loss on holding Global Cord will be expected to be smaller as well. Even though it is essential to pay attention to Global Cord Blood current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Global Cord Blood exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Global Cord Blood has an expected return of -0.19%. Please be advised to check out Global Cord sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change to decide if Global Cord Blood performance from the past will be repeated at some point in the near future.
Global Cord financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of Global Cord, including all of Global Cord's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Global Cord assets, the company is considered highly leveraged. Understanding the composition and structure of overall Global Cord debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it.
Please read more on our technical analysis page.

Understanding Global Total Debt

Global Cord Blood liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. Global Cord Blood has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on Global Cord balance sheet include debt obligations and money owed to different Global Cord vendors, workers, and loan providers. Below is the chart of Global main long-term debt accounts currently reported on its balance sheet.
You can use Global Cord Blood financial leverage analysis tool to get a better grip on understanding its financial position

How important is Global Cord's Liquidity

Global Cord financial leverage refers to using borrowed capital as a funding source to finance Global Cord Blood ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Global Cord financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Global Cord's total debt and its cash.

Purchase by Mccarthy Kent C of 78400 shares of Global Cord

Legal trades by Global Cord insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Global insider trading alert for perchase of common stock by Mccarthy Kent C, the corporate stakeholder, on 18th of December 2021. This event was filed by Global Cord Blood Corp with SEC on 2014-12-18. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper look at Global

Global Cord Blood generated the yearly revenue of 1.25 B. Reported Net Income was 524.08 M with gross profit of 980.69 M.

Asset Breakdown

1.8 B
Assets Non Current
5.9 B
Current Assets
Total Assets7.68 Billion
Current Assets5.87 Billion
Assets Non Current1.81 Billion
Goodwill87.67 Million
Tax Assets69.29 Million

Will Global continue to rise?

Latest Risk Adjusted Performance is up to -0.03. Price may slide again. Global Cord Blood is displaying above-average volatility over the selected time horizon. Investors should scrutinize Global Cord Blood independently to ensure intended market timing strategies are aligned with expectations about Global Cord volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Global Cord's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Global Cord's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Global Cord Implied Volatility

Global Cord's implied volatility exposes the market's sentiment of Global Cord Blood stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Global Cord's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Global Cord stock will not fluctuate a lot when Global Cord's options are near their expiration.

Our Final Perspective on Global Cord

Whereas some other firms in the diagnostics & research industry are either recovering or due for a correction, Global Cord may not be performing as strong as the other in terms of long-term growth potentials. Taking everything into account, as of the 4th of July 2022, we believe that at this point, Global Cord is very risky with close to average odds of financial distress within the next 2 years. From a slightly different point of view, the entity appears to be undervalued. Our actual 90 days 'Buy-Sell' recommendation on the company is Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Global Cord Blood. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to